摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ochropine | 2299-25-4

中文名称
——
中文别名
——
英文名称
ochropine
英文别名
——
ochropine化学式
CAS
2299-25-4
化学式
C23H28N2O4
mdl
——
分子量
396.486
InChiKey
SCEZUKWTQWFYLN-SJLJAKESSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    558.3±50.0 °C(Predicted)
  • 密度:
    1.26±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.98
  • 重原子数:
    29.0
  • 可旋转键数:
    2.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    60.77
  • 氢给体数:
    0.0
  • 氢受体数:
    6.0

SDS

SDS:7a0071f111e28c194524ca0862cc9e46
查看

反应信息

  • 作为产物:
    描述:
    (2R,6S,12bS,13S)-3-Eth-(E)-ylidene-10-methoxy-12-methyl-1,3,4,7,12,12b-hexahydro-2H,6H-2,6-methano-indolo[2,3-a]quinolizine-13-carbonitrile 在 palladium on activated charcoal 吡啶chromium(VI) oxide硫酸 、 ammonium acetate 、 氢气 、 sodium carbonate 、 溶剂黄146 作用下, 以 四氢呋喃 为溶剂, 反应 3.5h, 生成 ochropine
    参考文献:
    名称:
    Sakai, Shin-ichiro; Yamamoto, Yoshikuni; Hasegawa, Sugio, Heterocycles, 1980, vol. 14, # 1, p. 85
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Sakai, Shin-Ichiro; Yamamoto, Yoshikuni; Hasegawa, Sugio, Chemical and pharmaceutical bulletin, 1980, vol. 28, # 11, p. 3454 - 3456
    作者:Sakai, Shin-Ichiro、Yamamoto, Yoshikuni、Hasegawa, Sugio
    DOI:——
    日期:——
  • Sakai, Shin-ichiro; Yamamoto, Yoshikuni; Hasegawa, Sugio, Heterocycles, 1980, vol. 14, # 1, p. 85
    作者:Sakai, Shin-ichiro、Yamamoto, Yoshikuni、Hasegawa, Sugio
    DOI:——
    日期:——
查看更多

同类化合物

甲基(5E)-5-亚乙基-8-羰基-2,3,4,5,6,7,8,9-八氢-1H-2,6-亚甲基吖癸英并[5,4-b]吲哚-14-羧酸酯盐酸 Methyl 3-oxovobasan-17-oate (-)-Tabernemontanine Tabernaemontanin hydrochloride 16-Epidregamine hydrochloride Dregamine, hydrochloride Perivinol dregamine tabernaemontanine Affinine methyl 11-acetyloxy-12-ethyl-4-[(15E)-15-ethylidene-18-methoxycarbonyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate methyl (1S,12S,15E,16R)-15-ethylidene-6-methoxy-19-oxa-3,13-diazapentacyclo[14.3.1.02,10.04,9.012,17]icosa-2(10),4(9),5,7-tetraene-13-carboxylate Vobasan-17-oic acid, 3-oxo-, methyl ester Perivine sulfate Epi-16 ochropamine chlorhydrate Methyl 3-acetyl-5-ethylidene-2,3,4,5,6,7,8,9-octahydro-8-oxo-2,6-methano-1H-azecino(5,4-b)indole-14-carboxylate ochropine O-Acetylvincadiffin gelsempervine-A (19Z)-Anhydrovobasinediol (3R)-3,17-epoxy-vobasane Epi-16-Perivin methyl (1S,14R,15Z,18S)-15-ethylidene-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate perivine vobasinediol affinine benzyl (1S,12S,14R,15E,18S)-15-ethylidene-12-hydroxy-18-[tri(propan-2-yl)silyloxymethyl]-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-17-carboxylate Periformyline Vobasan-17-oic acid, 3-oxo-, methyl ester, (16R)- 2,2,2-trichloroethyl (1S,12S,15E,16R)-15-ethylidene-6-methoxy-19-oxa-3,13-diazapentacyclo[14.3.1.02,10.04,9.012,17]icosa-2(10),4(9),5,7-tetraene-13-carboxylate Tabernaemontanin Vobasin methyl (1R,14R,15E)-15-ethylidene-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate (15E)-15-ethylidene-13-methyl-19-oxa-3,13-diazapentacyclo[14.3.1.02,10.04,9.012,17]icosa-2(10),4,6,8-tetraene 3-Oxovobasan-17-oic acid, methyl ester methyl (15Z)-15-ethylidene-10,17-dimethyl-12-oxo-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate methyl (1S,14R,15E,18R)-15-ethylidene-12-oxo-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate 20-Epi-19,20-dihydro-decarbomethoxy vobasine Vobasan Epi-16-Ochropamin methyl (1R,14R,15R,18R)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate (15E)-15-ethylidene-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-one methyl (1S,14S,15E,18S)-15-ethylidene-17-methyl-17-oxido-12-oxo-10-aza-17-azoniatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate (1R,14R,18S)-15-ethylidene-17,18-dimethyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene methyl 15-ethylidene-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate;hydrochloride methyl (12R,13R,15S,17S)-13-ethyl-5-[(1S,12S,14R,15E,18S)-15-ethylidene-18-(hydroxymethyl)-18-methoxycarbonyl-17-methyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-4-methoxy-1,11-diazapentacyclo[13.3.1.02,7.08,18.012,17]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate Vobasivindoline Methyl (1S,15E)-15-ethylidene-12-oxo-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate methyl (1S,12S,15E)-15-ethylidene-12-hydroxy-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate Pagicerine